Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (City of Hope Medical Center)

N/A

Report date: 2023/05/06 09:01:28

Base Information

Drug NameAutologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (City of Hope Medical Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsLymphoproliferative DisordersLymphoma, Mantle-CellLymphoma, Follicular +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesCity Of Hope National Medical Center
Inactive CompaniesN/A
Active IndicationsLymphoproliferative DisordersLymphoma, Mantle-CellLymphoma, Follicular +[14] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A